Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HIGD2A pseudogene 1 (HIGD2AP1) is a non-protein-coding genomic element located on human chromosome 2[9]. It is classified as a pseudogene of the HIG1 hypoxia inducible domain family member 2A gene (HIGD2A)[3][9]. Unlike the functional HIGD2A gene, which encodes an inner mitochondrial membrane protein involved in the assembly and function of respiratory supercomplexes (cytochrome c oxidase complex IV)[5], HIGD2AP1 does not produce a functional protein product and has no reported biological or therapeutic roles[9]. There are no disease associations, biomarkers, or drug interactions known for HIGD2AP1. This entry should not be considered a valid therapeutic target. If detailed information about the protein-coding gene HIGD2A is needed, that should be requested separately, as HIGD2A itself is involved in mitochondrial respiratory chain activity and hypoxia-response[5][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HIGD2A pseudogene 1 (HIGD2AP1).